KAYLEY MCMAHON: Open Payments
NPI 1851932032 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 31 payments from 9 companies in 2025. Trend: 2023 $1,351 · 2024 $810 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $259 |
| E.R. Squibb & Sons, L.L.C. | 9 | $178 |
| GlaxoSmithKline, LLC. | 3 | $154 |
| Janssen Biotech, Inc. | 2 | $130 |
| Amgen Inc. | 4 | $76 |
| PFIZER INC. | 2 | $47 |
| UCB, Inc. | 1 | $25 |
| SOBI, INC | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: SAPHNELO, ORENCIA, BENLYSTA, TREMFYA, XELJANZ, ENBREL, Bimzelx, OTEZLA.
Industry payments across PA — which companies pay providers there.
